PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Revenue by Segment

Period Ending	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Collaboration	998.36M	998.73M	989.48M	986.54M	304.00K	100.02M	100.02M	100.02M
Collaboration Growth	328,306.91%	898.49%	889.24%	886.30%	-99.70%	294,088.24%	99.84%	99.84%
Net Product	586.70M	557.42M	561.88M	576.77M	600.95M	601.31M	609.92M	651.30M
Net Product Growth	-2.37%	-7.30%	-7.88%	-11.44%	-9.12%	-5.11%	-2.23%	9.84%
Royalty	244.22M	223.00M	213.57M	209.15M	203.86M	196.70M	185.51M	169.18M
Royalty Growth	19.80%	13.37%	15.13%	23.63%	20.73%	24.71%	32.05%	34.85%
Manufacturing	-98.63M	-	-	301.00K	1.66M	2.63M	5.00M	7.06M
Manufacturing Growth	-	-	-	-95.74%	-78.39%	-60.81%	14.85%	255.08%

Revenue by Product

Period Ending	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Translarna	235.30M	290.17M	311.80M	322.70M	340.30M	321.50M	318.20M	344.30M
Translarna Growth	-30.86%	-9.75%	-2.01%	-6.27%	-4.36%	-4.43%	-7.50%	6.10%
Emflaza	146.36M	169.56M	186.30M	197.20M	206.70M	224.10M	239.60M	258.00M
Emflaza Growth	-29.19%	-24.34%	-22.25%	-23.57%	-18.97%	-8.83%	2.74%	15.02%

Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.